School of Medicine
Showing 51-100 of 2,382 Results
-
Burak Alsan, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsPilot Study on the Use of Televisits for Transition Education for Young Adults with Chronic Disease
-
Emily Alsentzer
Assistant Professor of Biomedical Data Science, of Medicine (Biomedical Informatics Research) and, by courtesy, of Computer Science
BioDr. Emily Alsentzer is an Assistant Professor in Biomedical Data Science and, by courtesy, Computer Science at Stanford University. Her research leverages machine learning (ML) and natural language processing (NLP) to augment clinical decision-making and broaden access to high quality healthcare. She focuses on integrating medical expertise into ML models to ensure responsible deployment in clinical workflows. Dr. Alsentzer completed a postdoctoral fellowship at Brigham and Women’s Hospital where she worked to deploy ML models within the Mass General Brigham healthcare system. She received her PhD from the Health Sciences and Technology program at MIT and Harvard Medical School and holds degrees in computer science (BS) and biomedical informatics (MS) from Stanford University. She has served as General Chair for the Machine Learning for Health Symposium and founding organizer for SAIL and the Conference on Health, Inference, and Learning (CHIL).
-
Russ B. Altman
Kenneth Fong Professor and Professor of Bioengineering, of Genetics, of Medicine, of Biomedical Data Science, Senior Fellow at the Stanford Institute for Human-Centered AI and Professor, by courtesy, of Computer Science
Current Research and Scholarly InterestsI refer you to my web page for detailed list of interests, projects and publications. In addition to pressing the link here, you can search "Russ Altman" on http://www.google.com/
-
Maryam Amirahmadi
Postdoctoral Scholar, Cardiovascular Medicine
BioDr. Maryam Amirahmadi is a microsurgery expert and postdoctoral research fellow at Stanford Cardiovascular Institute. She obtained her Doctor of Medicine (MD) degree from Hamadan University of Medical Sciences. After more than a year of experience as a Family and Emergency Physician, she spent around 4 years at the Department of Cardiovascular Surgery of Shiraz University of Medical Sciences where she served as a pediatric and adult Cardiac Intensive Care physician and received training in cardiovascular surgery at Namazi and Faghihi hospitals. She then spent a year in the Department of Vascular Surgery at the University of Miami, Miller School of Medicine, serving as a postdoctoral researcher and performing microsurgery on animals, with her research focused on therapeutic strategies to improve neovascularization after limb ischemia. Dr. Amirahmadi joined Stanford Cardiovascular Institute in 2022 where she is now a postdoctoral research fellow under the supervision of Prof. Philip S. Tsao, a renowned cardiovascular scientist. Her research interests and practical expertise include Microsurgery, and the effect of e-cigarette vaping on factors of inflammatory or immune pathways that can subsequently be related to the molecular mechanisms involved in angiogenesis and arteriogenesis in the murine model of hindlimb ischemia, as well as the mechanisms of e-cigarette and nicotine’s effects in augmenting Abdominal Aortic Aneurysm (AAA) in rodent models of aortic aneurysm, including porcine pancreatic elastase-induced AAA. Dr. Maryam Amirahmadi and her colleagues are currently investigating the transgenerational effects of vaping/nicotine on abdominal aortic aneurysm (AAA) risk.
-
Daniel Kwasi Amponsah
Affiliate, Department Funds
Fellow in Medicine - Med/Cardiovascular MedicineBioDr. Daniel Amponsah was born and raised in Loma Linda, California. He graduated with a BS in Biochemistry from Pacific Union College in Northern California and received his MD from Loma Linda University School of Medicine where he graduated AOA. He completed his internal medicine residency at Massachusetts General Hospital and was appointed the Simulation Chief his senior year. He is interested in pursuing an academic career in interventional cardiology with a focus on outcomes and health disparities. Prior research work has explored outcomes in ischemic time in patients with cardiogenic shock and STEMI with Dr. Anthony Hilliard, disparities in the management of aortic stenosis alongside Dr. Sammy Elmariah, defining type 2 MI using coronary CT with Dr. James Januzzi. He is presently engaged in assessing the potential applications of angiography-derived FFR and IMR across various coronary disease syndromes with Dr. Bill Fearon and investigating disparities in advanced structural interventions with Dr. Celina Yong.
-
Shuchi Anand
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsManagement of CKD and ESRD in low-resource settings
Tubulointerstitial disease
Chronic kidney disease of unknown etiology
ESRD and physical activity
ESRD and vitamin D deficiency -
Nidharshan Anandasivam
Affiliate, Department Funds
Fellow in Medicine - Med/NephrologyBioNidharshan Anandasivam is a fellow in the Stanford University Nephrology Fellowship Program. He received a Bachelor of Science in Biological Engineering at MIT, an MD from Yale School of Medicine, and an MBA from Yale School of Management. He completed his Internal Medicine Residency at University of Texas at Austin Dell Medical School.
-
Christine Anastasiou, MD, MAS
Clinical Assistant Professor, Medicine - Immunology & Rheumatology
BioDr. Anastasiou is a board-certified, fellowship-trained rheumatologist with the Stanford Health Care Immunology and Rheumatology Clinic. She is also a clinical assistant professor in the Department of Medicine, Division of Immunology and Rheumatology at Stanford University School of Medicine.
Dr. Anastasiou specializes in diagnosing and treating patients with rheumatic diseases. She has a special interest in ankylosing spondylitis, systemic lupus erythematosus, rheumatoid arthritis, and idiopathic inflammatory myopathies.
Her scholarly work includes epidemiologic studies and clinical trials focused on improving safety and health outcomes for people with chronic rheumatic diseases. Dr. Anastasiou has served as an investigator and collaborator for clinical trials of new therapies to treat rheumatic disease. She is actively involved in medical education through developing and leading patient, medical student, resident, and fellow educational programs.
Dr. Anastasiou is a member of the American College of Rheumatology (ACR). She has published her research in peer-reviewed journals, including Arthritis Care & Research and Lupus Science & Medicine. She has delivered lectures and presentations across the country and abroad on various topics related to rheumatology. -
Chad Anderson
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioChad Anderson is a Physician Assistant at Stanford ValleyCare and a Clinical Assistant Professor with the Stanford School of Medicine MSPA program. He is the Assistant Director of PA education at ValleyCare. He is dual credentialed as a Family Nurse Practitioner and a Physician Assistant. He completed his FNP/PA training at the Stanford School of Medicine and his graduate studies at A.T. Still University – Arizona School of Health Sciences. He is passionate about improving our patients hospital experience as well as educating our future providers.
-
Jason Andrews
Professor of Medicine (Infectious Diseases) and, by courtesy, of Epidemology
Current Research and Scholarly InterestsOur laboratory aims to develop and test innovative approaches to the diagnosis, treatment and control of infectious diseases in resource-limited settings. We draw upon multiple fields including mathematical modeling, microbial genetics, field epidemiology, statistical inference and biodesign to work on challenging problems in infectious diseases, with an emphasis on tuberculosis and tropical diseases.
-
Justin P. Annes M.D., Ph.D.
Associate Professor of Medicine (Endocrinology)
Current Research and Scholarly InterestsThe ANNES LABORATORY of Molecular Endocrinology: Leveraging Chemical Biology to Treat Endocrine Disorders
DIABETES
The prevalence of diabetes is increasing at a staggering rate. By the year 2050 an astounding 25% of Americans will be diabetic. The goal of my research is to uncover therapeutic strategies to stymie the ensuing diabetes epidemic. To achieve this goal we have developed a variety of innovate experimental approaches to uncover novel approaches to curing diabetes.
(1) Beta-Cell Regeneration: Diabetes results from either an absolute or relative deficiency in insulin production. Our therapeutic strategy is to stimulate the regeneration of insulin-producing beta-cells to enhance an individual’s insulin secretion capacity. We have developed a unique high-throughput chemical screening platform which we use to identify small molecules that promote beta-cell growth. This work has led to the identification of key molecular pathways (therapeutic targets) and candidate drugs that promote the growth and regeneration of islet beta-cells. Our goal is to utilize these discoveries to treat and prevent diabetes.
(2) The Metabolic Syndrome: A major cause of the diabetes epidemic is the rise in obesity which leads to a cluster of diabetes- and cardiovascular disease-related metabolic abnormalities that shorten life expectancy. These physiologic aberrations are collectively termed the Metabolic Syndrome (MS). My laboratory has developed an original in vivo screening platform t to identify novel hormones that influence the behaviors (excess caloric consumption, deficient exercise and disrupted sleep-wake cycles) and the metabolic abnormalities caused by obesity. We aim to manipulate these hormone levels to prevent the development and detrimental consequences of the MS.
HEREDIATY PARAGAGLIOMA SYNDROME
The Hereditary Paraganglioma Syndrome (hPGL) is a rare genetic cancer syndrome that is most commonly caused by a defect in mitochondrial metabolism. Our goal is to understand how altered cellular metabolism leads to the development of cancer. Although hPGL is uncommon, it serves as an excellent model for the abnormal metabolic behavior displayed by nearly all cancers. Our goal is to develop novel therapeutic strategies that target the abnormal behavior of cancer cells. In the laboratory we have developed hPGL mouse models and use high throughput chemical screening to identify the therapeutic susceptibilities that result from the abnormal metabolic behavior of cancer cells.
As a physician scientist trained in clinical genetics I have developed expertise in hereditary endocrine disorders and devoted my efforts to treating families affected by the hPGL syndrome. By leveraging our laboratory expertise in the hPGL syndrome, our care for individuals who have inherited the hPGL syndrome is at the forefront of medicine. Our goal is to translate our laboratory discoveries to the treatment of affected families. -
Sally Arai
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsResearch interest in utilizing post-transplant adoptive cellular immunotherapy to reduce GVHD and relapse in patients with high risk hematologic malignancies.
-
Danit Ariel
Clinical Associate Professor, Medicine - Endocrinology, Gerontology, & Metabolism
BioDanit Ariel, MD MS, is board certified in Endocrinology. Dr. Ariel graduated from UC Davis School of Medicine. She then completed a residency in Internal Medicine at Stanford and a fellowship and post-doctorate in Endocrinology and Metabolism at Stanford before joining the faculty at Stanford.
Dr. Ariel practices general endocrinology, with a special interest in menopause, LGBTQ+ health, transgender medicine, reproductive endocrinology and thyroid disorders amongst others.
She believes in practicing compassionate care: in listening to her patients’ concerns, respecting their values, communicating well, and providing an evidence-based approach to help guide individualized treatment plans. She is deeply committed to utilizing her expertise in the field of endocrinology to optimize her patients’ health and well-being.
Dr. Ariel is passionate about medical education and teaching, and serves on the teaching faculty in the Stanford University School of Medicine. She completed an honors certificate in medical education from Stanford. She is the Founding Director of the Student Guidance Program for medical students. Finally, within the division of Endocrinology, she is the Director of Faculty Wellness.
Appointments with with Dr. Ariel are available in the Hoover Pavilion on 211 Quarry Road as part of the Stanford Health Care Endocrinology Clinic and the Stanford Health Care LGBTQ+ Health Program. -
Julia Anne Armendariz
Clinical Assistant Professor (Affiliated), Med/Hospital Medicine
BioI have a passion for medical education and underserved patient communities, so my job at the Palo Alto VA suits me perfectly. I have the joy of being a course director for the Stanford Internal Medicine Medical Education Elective (along with Drs. Sharmin Shekarchian and Poonam Hosamani), which is one of my very favorite things in life. The best things about being a doctor are learning new things each day, bearing witness to the human experience of illness, and taking part in relieving suffering and promoting health within my community. My hobbies include anything outdoors, working in my garden, and baking up delicious treats.
-
Lucia Aronica
Casual Employee, Medicine - Med/Stanford Prevention Research Center
BioDr. Lucia Aronica is an epigenetics and nutrigenomics scientist at Stanford University School of Medicine with over 17 years of research experience. She created Stanford's first courses in nutritional epigenetics and longevity medicine, and developed "epinutrition," a framework for optimizing gene expression through diet.
Featured in the 2024 Netflix documentary "You Are What You Eat: A Twin Experiment," Dr. Aronica is a TEDx speaker who presents to 10,000+ clinicians annually. She has published 25+ peer-reviewed papers in top journals including Cell and BMC Medicine, and secured over $1 million in competitive research funding.
Dr. Aronica received her PhD in epigenetics from the University of Vienna (2010) and conducted research at Oxford and USC. She serves on scientific advisory boards in precision health and longevity medicine. -
Anna Chen Arroyo, MD MPH
Clinical Associate Professor, Medicine - Pulmonary, Allergy & Critical Care Medicine
BioAnna Chen Arroyo, MD, MPH, is a board-certified allergy/immunology physician and clinical researcher. She is the section chief of Allergy, Asthma, and Immunodeficiency in the Division of Pulmonary, Allergy and Critical Care Medicine and the medical director of the Allergy, Asthma, and Immunodeficiency Clinic at Stanford Health Care. She specializes in diagnosing and treating allergic conditions, with a focus on severe asthma, maternal asthma, and drug (including chemotherapy) allergies.
Dr. Arroyo’s clinical research focuses on early life risk factors for allergic disease development and how allergic diseases impact people across the lifespan. She is also interested in studying how allergic diseases affect the Asian American population and hormonal influences on allergic diseases. She has published her original research in peer-reviewed scientific journals, such as The Journal of Allergy and Clinical Immunology: In Practice and The Journal of the American Medical Association (JAMA). She has also presented at national conferences, including annual meetings for the American Thoracic Society and the American Academy of Asthma, Allergy, and Immunology. Dr. Arroyo is a member of the American Academy of Asthma, Allergy, and Immunology, the American Thoracic Society, and the American College of Allergy, Asthma, and Immunology. -
Maja Artandi, MD
Clinical Professor, Medicine - Primary Care and Population Health
BioDr. Artandi is a Professor of Medicine in the Division of Primary Care and Population Health at Stanford. She is a leader in Primary Care, spearheading novel methods of health care delivery and education. She offers an impressive clinical background and has received several educational and leadership awards.
Her expertise lies in the development and implementation of a medical curriculum focused on the patient-physician interaction, emphasizing communication skills, physical examination skills and medical decision making to support best clinical practices.
Dr. Artandi is a dedicated Primary Care physician and educator and has served as a mentor for many students, residents and colleagues. She is currently the mentorship lead for the Division of Primary Care and Population Health.
She is in the process of getting an executive coaching certification and is faculty for the Advancing Communication Excellence at Stanford Program with the goal of helping her colleagues improve their communication skills.
From 2013-2021 she was the Co-Director of Primary Care education for the Stanford Internal Medicine residency program and co-founded and co-directed the Primary Care program (ACE) within the Stanford Internal Medicine Residency program.
Dr. Artandi is currently the Co-President of the Society of Bedside Medicine, an international society dedicated to studying and improving the patient/physician interaction.
She is a fellow of the Royal College of Physicians Edinburgh and of the American College of Physicians and currently serves as the Wellness chair for the Northern California ACP chapter. -
Steven Artandi, MD, PhD
Laurie Kraus Lacob Director of the Stanford Cancer Institute (SCI), Jerome and Daisy Low Gilbert Professor and Professor of Biochemistry
Current Research and Scholarly InterestsTelomeres are nucleoprotein complexes that protect chromosome ends and shorten with cell division and aging. We are interested in how telomere shortening influences cancer, stem cell function, aging and human disease. Telomerase is a reverse transcriptase that synthesizes telomere repeats and is expressed in stem cells and in cancer. We have found that telomerase also regulates stem cells and we are pursuing the function of telomerase through diverse genetic and biochemical approaches.
-
Steven Asch
Professor of Medicine (Primary Care and Population Health) and, by courtesy, of Health Policy
Current Research and Scholarly InterestsDescribe your current research interest and activities
-
Yusuf Ashktorab
Contingent Employee, Medicine - Med/Nephrology
BioYusuf Ashktorab is a medical student (Class of 2028) at Howard University College of Medicine (HUCM). His journey in medicine is driven by a passion for using technology, to reduce health disparities and improve patient care.
He has contributed to projects at Stanford University, the University of California, San Francisco (UCSF), and the National Institutes of Health (NIH), focusing on topics such as predictive modeling for vaccine responses, the role of viruses in cancer development, and the use of Machine Learning and Large Language Models to diagnose Chronic Kidney Disease of Unknown Etiology (CKDu).
At HUCM, Yusuf serves as President of the Health Innovation and Technology (HIT) interest group and Vice President of Research and Technology for his class. In these roles, he is working to build a strong community centered on innovation and collaboration. -
Euan A. Ashley
Roger and Joelle Burnell Professor of Genomics and Precision Health, Arthur L. Bloomfield Professor of Medicine and Professor of Genetics, of Biomedical Data Science and, by courtesy, of Pathology
Current Research and Scholarly InterestsThe Ashley lab is focused on precision medicine. We develop methods for the interpretation of whole genome sequencing data to improve the diagnosis of genetic disease and to personalize the practice of medicine. At the wet bench, we take advantage of cell systems, transgenic models and microsurgical models of disease to prove causality in biological pathways and find targets for therapeutic development.
-
Rabia Aslam
Affiliate, Medicine - Primary Care and Population Health
BioM.D., University of California, Davis
B.A. in Public Health, University of California, Berkeley
My interest lies at the intersection of medicine and public health and I strive to work towards alleviating socioeconomic disparities in healthcare and education. -
Themistocles (Tim) Assimes
Associate Professor of Medicine (Cardiovascular Medicine) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsGenetic Epidemiology, Genetic Determinants of Complex Traits related to Cardiovasular Medicine, Coronary Artery Disease related pathway analyses and integrative genomics, Mendelian randomization studies, risk prediction for major adverse cardiovascular events, cardiovascular medicine related pharmacogenomics, ethnic differences in the determinants of Insulin Mediated Glucose Uptake, pharmacoepidemiology of cardiovascular drugs & outcomes
-
Danielle Francoise Atibalentja, MD, PhD
Instructor, Medicine - Oncology
BioDanielle F Atibalentja received her PhD in Immunology at Washington University in St Louis and her MD at UCSF School of medicine. She trained in Internal medicine at Washington University/Barnes-Jewish Hospital in St Louis and recently completed Hematology/Oncology Fellowship at Stanford. Her primary clinical interest is in treating patients with B-cell lymphomas. Her long-term research goals are to better understand B-cell responses in the setting of malignancy to develop immune-based therapies for cancer treatment. She currently studies how the MYC oncogene shapes B-cell and antibody responses during T-cell lymphomagenesis.
